Selva Therapeutics is a privately held biotechnology company dedicated to the development of therapeutics for infectious diseases. The company’s lead drug candidate, SLV213, is an orally available small molecule novel antiviral therapy with activity against a broad range of viruses that threaten global health, including SARS-CoV-2, the virus causing COVID-19. In addition, SLV213 has activity against Ebola and Nipah viruses and has completed preclinical development as a potential therapy against Chagas disease. Selva is headquartered in San Diego.
View Top Employees from Selva Therapeutics| Website | http://www.selvarx.com |
| Employees | 4 (3 on RocketReach) |
| Founded | 2017 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Drug Discovery, Biotechnology |
Looking for a particular Selva Therapeutics employee's phone or email?
Selva Therapeutics Questions
Ted Daley is the Co-Founder and Chief Executive Officer of Selva Therapeutics.
3 people are employed at Selva Therapeutics.
Selva Therapeutics is based in San Diego, California.
Top Selva Therapeutics Employees
-
45+
-
43
-
21
Related Companies
